The House of Commons health committee report, which was delivered in January, 2008 found that NICE was taking more time for assessing new medicines and in recommending the abandonment of older, ineffective therapies. It also found irregularities in the NICE’s guidance concerning the national health service.
But the government commended NICE’s role in promoting cost-effective healthcare and dismissed several of the committee’s recommendations, as operational matters for NICE itself.